Sequenom, Inc. (NASDAQ: SQNM) is focused on providing superior genetic analysis products designed to translate genomic science into advanced solutions for biomedical research, agricultural applications, molecular medicine and non-invasive prenatal diagnostics research, and possibly clinical utility. MassARRAY, the company’s high-performance DNA analysis platform, efficiently and precisely measures the amount of genetic target material as well as the variations within. For further information, visit the Company’s web site at www.sequenom.com.
- 18 years ago
QualityStocks
Sequenom, Inc. (NASDAQ: SQNM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – HWAL Inc. (HWAL) Brings Music Royalties to the Tokenized RWA Market
HWAL (OTCID: HWAL) is pursuing a tokenized approach to music royalties as the broader real-world…
-
QualityStocksNewsBreaks – Streamex Corp. (NASDAQ: STEX) Announces $1 Million Institutional Allocation to GLDY-Based Investment Strategy
Streamex (NASDAQ: STEX) announced that an institutional investment manager has launched an investment strategy using…
-
QualityStocksNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Signs 12-Month Technology Services Agreement with AQUAE Holdings
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations Inc. signed a 12-month technology…